|
End-of-day quote
Egyptian Exchange
09/11/2026
|
5-day change | 1st Jan Change | ||
| 303.61 EGP | +5.42% |
|
+15.43% | +202.94% |
| Market Cap | 15.18B 282M 251M 231M 210M 398M 26.41B 408M 2.77B 1.1B 14.14B 1.06B 1.03B 44.53B | P/E 2025 |
11.7x | P/E 2026 | 32x |
|---|---|---|---|---|---|
| Enterprise Value | 16.72B 310M 277M 255M 231M 438M 29.08B 449M 3.05B 1.21B 15.57B 1.16B 1.14B 49.04B | EV / Sales 2025 |
1.89x | EV / Sales 2026 | 4.56x |
| Free-Float |
20.38% | Yield 2025 |
4.1% | Yield 2026 | - |
| 1 day | +5.42% | ||
| 1 week | +15.43% | ||
| Current month | +7.28% | ||
| 1 month | -3.77% | ||
| 3 months | -15.43% | ||
| 6 months | +92.28% | ||
| Current year | +202.94% |
| 1 week | 268 |  | 312 |
| 1 month | 205 | | 318.8 |
| Current year | 87 | | 516.96 |
| 1 year | 87 | | 516.96 |
| 3 years | 41.3 | | 516.96 |
| 5 years | 24 | | 516.96 |
| 10 years | 8.51 | | 516.96 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | - | |
| Director of Finance/CFO | - | - | |
| Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.42% | +15.43% | +183.54% | +323.09% | 282M | |
| +4.28% | +0.07% | +52.75% | +138.78% | 1,258B | |
| +2.13% | +4.27% | +51.21% | +91.36% | 679B | |
| +0.68% | +1.54% | +33.83% | +112.47% | 518B | |
| -0.56% | +2.15% | +43.21% | +68.70% | 390B | |
| +1.38% | +0.27% | +72.42% | +45.30% | 367B | |
| +0.30% | +1.99% | +31.23% | +59.93% | 307B | |
| -0.60% | +1.76% | +6.68% | +38.77% | 293B | |
| +1.04% | -0.05% | +45.29% | +76.18% | 252B | |
| +1.46% | -0.59% | +42.48% | +125.82% | 210B | |
| Average | +0.92% | +2.03% | +56.26% | +108.04% | 427B | |
| Weighted average by Cap. | +0.45% | +1.18% | +45.39% | +96.81% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 1.29B 23.93M 21.36M 19.66M 17.84M 33.81M 2.24B 34.65M 235M 93.72M 1.2B 89.83M 87.91M 3.78B | 2.13B 39.6M 35.35M 32.53M 29.52M 55.95M 3.71B 57.34M 389M 155M 1.99B 149M 145M 6.26B |
| Net income | 126M 2.33M 2.08M 1.92M 1.74M 3.3M 219M 3.38M 22.93M 9.14M 117M 8.76M 8.57M 369M | 256M 4.76M 4.25M 3.91M 3.55M 6.72M 446M 6.89M 46.75M 18.63M 239M 17.86M 17.48M 752M |
| Net Debt | 967M 17.95M 16.02M 14.75M 13.38M 25.36M 1.68B 25.99M 176M 70.31M 901M 67.38M 65.94M 2.84B | 1.54B 28.53M 25.46M 23.43M 21.26M 40.3M 2.67B 41.3M 280M 112M 1.43B 107M 105M 4.51B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/11/26 | EGP 303.61 | +5.42% | 848,099 |
| 08/11/26 | EGP 288.01 | +2.49% | 588,949 |
| 05/11/26 | EGP 281.00 | +1.08% | 469,435 |
| 04/11/26 | EGP 278.00 | +1.46% | 513,510 |
| 03/11/26 | EGP 274.00 | +4.17% | 448,330 |
- Stock Market
- Stocks
- NIPH Stock
Select your edition
All financial news and data tailored to specific country editions
